Transcept Pharmaceuticals Inc 4
4 · Transcept Pharmaceuticals Inc · Filed Jul 18, 2013
Insider Transaction Report
Form 4
Singh Nikhilesh N
SVP & Chief Scientific Officer
Transactions
- Award
Common Stock Option (right to buy)
2013-07-15+115,000→ 115,000 totalExercise: $2.93Exp: 2023-07-15→ Common Stock (115,000 underlying)
Holdings
- 295(indirect: See footnote)
Common Stock
- 4,787
Common Stock
- 78,206(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]This total includes 2,088 shares purchased on May 31, 2013 under the 2009 Employee Stock Purchase Plan.
- [F2]Shares held directly by the Reporting Person's spouse.
- [F3]Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein.
- [F4]The option vests in forty-eight equal monthly installments beginning on August 15, 2013.